Glasgow Drug Firm Backed by Scottish National Investment Bank

Glasgow drug firm backed by Scottish National Investment Bank

Scottish life sciences firm has raised £19m to support 'one of the world’s most extensive clinical trials' of microbiome drugs to treat irritable…

Scottish biotech raises £19m to fund IBS drug trial

Glasgow-based life sciences scaleup EnteroBiotix has secured £19m to support its clinical trials of microbiome drugs used to treat irritable bowel syndrome (IBS).  IBS affects up to one in ten people, with up to twice as many women diagnosed compared to men.  The investment will fund the firm’s clinical trial for its EBX-102-02 IBS drug, which will involve around 300 patients. Top line efficacy data from the clinical trial is expected during the…

Gut health drugs firm EnteroBiotix raises £19m

Drugs developer EnteroBiotix has raised £19 million in one of the largest investments into a Scottish biotech company in recent years.